Paul Newhouse, M.D. holds the Jim Turner Chair in Cognitive Disorders at Vanderbilt University School of Medicine and is Professor of Psychiatry, Pharmacology, and Medicine. He is Director of the Vanderbilt Center for Cognitive Medicine (VCCM) in the Department of Psychiatry and Behavioral Sciences at Vanderbilt University Medical Center. The VCCM focuses on research studies of the cognitive basis of neuropsychiatric disease. Dr Newhouse established the Division of Geriatric Psychiatry Division and the Geriatric Psychiatry Fellowship at Vanderbilt and was the inaugural director of both. He is also a physician-scientist at the Veterans Affairs Tennessee Valley Health Systems Geriatric Research, Education, and Clinical Center (GRECC). He is an Army veteran and among other posts, served in the 3rd Infantry Division, directed a research laboratory for the Walter Reed Army Institute of Research, and served in Operation Desert Storm.
Current studies in his laboratory include leading a national study of the effects of nicotinic treatment for mild cognitive impairment, the treatment of post-cancer chemotherapy cognitive impairment, the development of novel muscarinic cholinergic agents for Alzheimer’s disease, cholinergic mechanisms in HIV and aging, studying new agents for the treatment of Alzheimer’s disease and cognitive impairment in older adults with Down syndrome, and the development of socially-assistive robots for dementia care. His research has been continuously funded by NIH since 1989 and he is funded currently by the National Institute on Aging, the Alzheimer’s Association, the Alzheimer’s Drug Discovery Foundation, and other private companies and foundations.